• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Challenges of COPD diagnosis.

作者信息

Price David, Brusselle Guy

机构信息

University of Aberdeen, Academic Primary Care, Division of Applied Health Sciences , Aberdeen , Scotland +44 1223 96 9808 ;

出版信息

Expert Opin Med Diagn. 2013 Nov;7(6):543-56. doi: 10.1517/17530059.2013.842552. Epub 2013 Oct 8.

DOI:10.1517/17530059.2013.842552
PMID:24099180
Abstract

INTRODUCTION

Chronic obstructive pulmonary disease (COPD) is a leading cause of death worldwide and this burden is predicted to increase unless exposure to risk factors is addressed. Diagnosis of COPD is a challenge: COPD is underdiagnosed and frequently misdiagnosed for asthma or other respiratory conditions. Although spirometry is only one parameter for establishing a clinical diagnosis of COPD, lack of routine spirometry is a key cause of COPD misdiagnosis. Differential diagnosis from asthma is essential because the treatment strategies for, and progression and outcomes of, the two conditions vary greatly.

AREAS COVERED

Here the authors review methods for the differential diagnosis of COPD and asthma; approaches to improve diagnosis, including case-finding and screening; the identification of specific COPD phenotypes and targeted therapy; and the potential role of exhaled biomarkers in the diagnosis of COPD.

EXPERT OPINION

Methods to diagnose COPD, specifically differential diagnosis from asthma, have improved in recent years. To translate these into clinical practice will require the development of combined guidelines for COPD and asthma that include COPD-asthma overlap syndrome and are based on evidence from randomized controlled trials.

摘要

相似文献

1
Challenges of COPD diagnosis.
Expert Opin Med Diagn. 2013 Nov;7(6):543-56. doi: 10.1517/17530059.2013.842552. Epub 2013 Oct 8.
2
Misdiagnosis of COPD and asthma in primary care patients 40 years of age and over.40岁及以上初级保健患者中慢性阻塞性肺疾病(COPD)和哮喘的误诊情况。
J Asthma. 2006 Jan-Feb;43(1):75-80. doi: 10.1080/02770900500448738.
3
Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma.呼出气成分分析有助于鉴别慢性阻塞性肺疾病和哮喘。
Am J Respir Crit Care Med. 2009 Dec 1;180(11):1076-82. doi: 10.1164/rccm.200906-0939OC. Epub 2009 Aug 27.
4
External validation of exhaled breath profiling using an electronic nose in the discrimination of asthma with fixed airways obstruction and chronic obstructive pulmonary disease.采用电子鼻技术对呼出气进行分析用于鉴别固定气道阻塞性疾病(如哮喘)与慢性阻塞性肺疾病的外部验证。
Clin Exp Allergy. 2011 Oct;41(10):1371-8. doi: 10.1111/j.1365-2222.2011.03800.x. Epub 2011 Jul 7.
5
Effects of corticosteroids on noninvasive biomarkers of inflammation in asthma and chronic obstructive pulmonary disease.皮质类固醇对哮喘和慢性阻塞性肺疾病炎症的无创生物标志物的影响。
Proc Am Thorac Soc. 2004;1(3):191-9. doi: 10.1513/pats.200402-011MS.
6
Exhaled breath condensate biomarkers in COPD.慢性阻塞性肺疾病中的呼出气冷凝物生物标志物
Eur Respir J. 2008 Aug;32(2):472-86. doi: 10.1183/09031936.00116107.
7
Clinical phenotypes of chronic obstructive pulmonary disease and asthma: recent advances.慢性阻塞性肺疾病和哮喘的临床表型:最新进展。
J Allergy Clin Immunol. 2013 Mar;131(3):627-34; quiz 635. doi: 10.1016/j.jaci.2013.01.010. Epub 2013 Jan 26.
8
Differentiating COPD from asthma in clinical practice.在临床实践中鉴别慢性阻塞性肺疾病与哮喘。
Postgrad Med. 2009 May;121(3):105-12. doi: 10.3810/pgm.2009.05.2009.
9
The clinical utility of biomarkers in asthma and COPD.生物标志物在哮喘和慢性阻塞性肺疾病中的临床应用
Curr Opin Pharmacol. 2008 Jun;8(3):222-35. doi: 10.1016/j.coph.2008.04.001. Epub 2008 May 28.
10
Asthma, chronic obstructive pulmonary disease (COPD), and the overlap syndrome.哮喘、慢性阻塞性肺疾病(COPD)和重叠综合征。
J Am Board Fam Med. 2013 Jul-Aug;26(4):470-7. doi: 10.3122/jabfm.2013.04.120256.

引用本文的文献

1
Cost-effectiveness of indacaterol/glycopyrronium in comparison with salmeterol/fluticasone combination for patients with moderate-to-severe chronic obstructive pulmonary disease: a LANTERN population analysis from Singapore.茚达特罗/格隆溴铵与沙美特罗/氟替卡松联合用药治疗中重度慢性阻塞性肺疾病患者的成本效益:来自新加坡的LANTERN人群分析
Singapore Med J. 2018 Jul;59(7):383-389. doi: 10.11622/smedj.2018022. Epub 2018 Mar 16.
2
Asthma and chronic obstructive pulmonary disease overlap syndrome (ACOS): structured literature review and physician insights.哮喘与慢性阻塞性肺疾病重叠综合征(ACOS):结构化文献综述及医生见解
Expert Rev Respir Med. 2016;10(3):363-71. doi: 10.1586/17476348.2016.1144476. Epub 2016 Feb 15.
3
Clinical characteristics of the asthma-COPD overlap syndrome--a systematic review.
哮喘-慢性阻塞性肺疾病重叠综合征的临床特征——一项系统综述
Int J Chron Obstruct Pulmon Dis. 2015 Jul 27;10:1443-54. doi: 10.2147/COPD.S85363. eCollection 2015.
4
Addressing unmet needs in the treatment of COPD.满足慢性阻塞性肺疾病治疗中未被满足的需求。
Eur Respir Rev. 2014 Sep;23(133):333-44. doi: 10.1183/09059180.00004014.